David M. Brown
机构:Heriot-Watt University Malaysia, Retina Consultants of Texas · ORCID:0000-0002-2570-5766
发表论文 440 篇 · 总被引 25171 次 · h-index 77
代表论文
- ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation (2024 · Ophthalmology Science · 被引 34)
- Microplastic-induced hepatic adverse effects evaluated in advanced quadruple cell human primary models following three weeks of repeated exposure (2024 · Chemosphere · 被引 24)
- Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema (2024 · JAMA Ophthalmology · 被引 17)
- Severe Spaceflight-Associated Neuro-Ocular Syndrome in an Astronaut With 2 Predisposing Factors (2024 · JAMA Ophthalmology · 被引 17)
- MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid (2024 · Ophthalmology · 被引 16)
- Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration (2024 · Scientific Reports · 被引 9)